IBDEI02J ; ; 12-JAN-2012
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JAN 12, 2012
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,3069,2)
 ;;=^19944
 ;;^UTILITY(U,$J,358.3,3070,0)
 ;;=780.31^^36^269^11
 ;;^UTILITY(U,$J,358.3,3070,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3070,1,4,0)
 ;;=4^780.31
 ;;^UTILITY(U,$J,358.3,3070,1,5,0)
 ;;=5^Convulsions, Febrile
 ;;^UTILITY(U,$J,358.3,3070,2)
 ;;=^28172
 ;;^UTILITY(U,$J,358.3,3071,0)
 ;;=331.0^^36^269^18
 ;;^UTILITY(U,$J,358.3,3071,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3071,1,4,0)
 ;;=4^331.0
 ;;^UTILITY(U,$J,358.3,3071,1,5,0)
 ;;=5^Dementia, Alzheimer'S
 ;;^UTILITY(U,$J,358.3,3071,2)
 ;;=^5679^294.10
 ;;^UTILITY(U,$J,358.3,3072,0)
 ;;=291.2^^36^269^17
 ;;^UTILITY(U,$J,358.3,3072,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3072,1,4,0)
 ;;=4^291.2
 ;;^UTILITY(U,$J,358.3,3072,1,5,0)
 ;;=5^Dementia, Alcoholic
 ;;^UTILITY(U,$J,358.3,3072,2)
 ;;=^268015
 ;;^UTILITY(U,$J,358.3,3073,0)
 ;;=290.40^^36^269^20
 ;;^UTILITY(U,$J,358.3,3073,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3073,1,4,0)
 ;;=4^290.40
 ;;^UTILITY(U,$J,358.3,3073,1,5,0)
 ;;=5^Dementia,Multi-Infarct
 ;;^UTILITY(U,$J,358.3,3073,2)
 ;;=^303487
 ;;^UTILITY(U,$J,358.3,3074,0)
 ;;=290.0^^36^269^65
 ;;^UTILITY(U,$J,358.3,3074,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3074,1,4,0)
 ;;=4^290.0
 ;;^UTILITY(U,$J,358.3,3074,1,5,0)
 ;;=5^Senile Dementia 
 ;;^UTILITY(U,$J,358.3,3074,2)
 ;;=^31703
 ;;^UTILITY(U,$J,358.3,3075,0)
 ;;=780.4^^36^269^74
 ;;^UTILITY(U,$J,358.3,3075,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3075,1,4,0)
 ;;=4^780.4
 ;;^UTILITY(U,$J,358.3,3075,1,5,0)
 ;;=5^Vertigo
 ;;^UTILITY(U,$J,358.3,3075,2)
 ;;=^35946
 ;;^UTILITY(U,$J,358.3,3076,0)
 ;;=345.90^^36^269^21
 ;;^UTILITY(U,$J,358.3,3076,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3076,1,4,0)
 ;;=4^345.90
 ;;^UTILITY(U,$J,358.3,3076,1,5,0)
 ;;=5^Epilepsy
 ;;^UTILITY(U,$J,358.3,3076,2)
 ;;=^268477
 ;;^UTILITY(U,$J,358.3,3077,0)
 ;;=355.1^^36^269^38
 ;;^UTILITY(U,$J,358.3,3077,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3077,1,4,0)
 ;;=4^355.1
 ;;^UTILITY(U,$J,358.3,3077,1,5,0)
 ;;=5^Meralgia Paresthetica
 ;;^UTILITY(U,$J,358.3,3077,2)
 ;;=^265141
 ;;^UTILITY(U,$J,358.3,3078,0)
 ;;=340.^^36^269^46
 ;;^UTILITY(U,$J,358.3,3078,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3078,1,4,0)
 ;;=4^340.
 ;;^UTILITY(U,$J,358.3,3078,1,5,0)
 ;;=5^Multiple Sclerosis
 ;;^UTILITY(U,$J,358.3,3078,2)
 ;;=^79761
 ;;^UTILITY(U,$J,358.3,3079,0)
 ;;=729.2^^36^269^47
 ;;^UTILITY(U,$J,358.3,3079,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3079,1,4,0)
 ;;=4^729.2
 ;;^UTILITY(U,$J,358.3,3079,1,5,0)
 ;;=5^Neuropathic Pain
 ;;^UTILITY(U,$J,358.3,3079,2)
 ;;=Neuropathic Pain^82605
 ;;^UTILITY(U,$J,358.3,3080,0)
 ;;=053.19^^36^269^54
 ;;^UTILITY(U,$J,358.3,3080,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3080,1,4,0)
 ;;=4^053.19
 ;;^UTILITY(U,$J,358.3,3080,1,5,0)
 ;;=5^Post-Herpetic Neuralgia
 ;;^UTILITY(U,$J,358.3,3080,2)
 ;;=^266544
 ;;^UTILITY(U,$J,358.3,3081,0)
 ;;=310.9^^36^269^48
 ;;^UTILITY(U,$J,358.3,3081,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3081,1,4,0)
 ;;=4^310.9
 ;;^UTILITY(U,$J,358.3,3081,1,5,0)
 ;;=5^Organic Brain Syndrome
 ;;^UTILITY(U,$J,358.3,3081,2)
 ;;=^123952
 ;;^UTILITY(U,$J,358.3,3082,0)
 ;;=332.0^^36^269^50
 ;;^UTILITY(U,$J,358.3,3082,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3082,1,4,0)
 ;;=4^332.0
 ;;^UTILITY(U,$J,358.3,3082,1,5,0)
 ;;=5^Parkinson'S Disease
 ;;^UTILITY(U,$J,358.3,3082,2)
 ;;=Parkinson's Disease^304847
 ;;^UTILITY(U,$J,358.3,3083,0)
 ;;=250.60^^36^269^51
 ;;^UTILITY(U,$J,358.3,3083,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3083,1,4,0)
 ;;=4^250.60
 ;;^UTILITY(U,$J,358.3,3083,1,5,0)
 ;;=5^Peripheral Neuropathy, Diabetic
 ;;^UTILITY(U,$J,358.3,3083,2)
 ;;=^267841^357.2
 ;;^UTILITY(U,$J,358.3,3084,0)
 ;;=356.9^^36^269^53
 ;;^UTILITY(U,$J,358.3,3084,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3084,1,4,0)
 ;;=4^356.9
 ;;^UTILITY(U,$J,358.3,3084,1,5,0)
 ;;=5^Peripheral Neuropathy, Unsp
 ;;^UTILITY(U,$J,358.3,3084,2)
 ;;=^123931
 ;;^UTILITY(U,$J,358.3,3085,0)
 ;;=780.2^^36^269^66
 ;;^UTILITY(U,$J,358.3,3085,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3085,1,4,0)
 ;;=4^780.2
 ;;^UTILITY(U,$J,358.3,3085,1,5,0)
 ;;=5^Syncope Or Presyncope
 ;;^UTILITY(U,$J,358.3,3085,2)
 ;;=^116707
 ;;^UTILITY(U,$J,358.3,3086,0)
 ;;=724.3^^36^269^62
 ;;^UTILITY(U,$J,358.3,3086,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3086,1,4,0)
 ;;=4^724.3
 ;;^UTILITY(U,$J,358.3,3086,1,5,0)
 ;;=5^Sciatica
 ;;^UTILITY(U,$J,358.3,3086,2)
 ;;=^108484
 ;;^UTILITY(U,$J,358.3,3087,0)
 ;;=780.39^^36^269^64
 ;;^UTILITY(U,$J,358.3,3087,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3087,1,4,0)
 ;;=4^780.39
 ;;^UTILITY(U,$J,358.3,3087,1,5,0)
 ;;=5^Seizure NOS
 ;;^UTILITY(U,$J,358.3,3087,2)
 ;;=^28162
 ;;^UTILITY(U,$J,358.3,3088,0)
 ;;=782.0^^36^269^49
 ;;^UTILITY(U,$J,358.3,3088,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3088,1,4,0)
 ;;=4^782.0
 ;;^UTILITY(U,$J,358.3,3088,1,5,0)
 ;;=5^Parasthesia
 ;;^UTILITY(U,$J,358.3,3088,2)
 ;;=Parasthesia^35757
 ;;^UTILITY(U,$J,358.3,3089,0)
 ;;=435.9^^36^269^71
 ;;^UTILITY(U,$J,358.3,3089,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3089,1,4,0)
 ;;=4^435.9
 ;;^UTILITY(U,$J,358.3,3089,1,5,0)
 ;;=5^Transient Ischemic Attack
 ;;^UTILITY(U,$J,358.3,3089,2)
 ;;=^21635
 ;;^UTILITY(U,$J,358.3,3090,0)
 ;;=354.2^^36^269^73
 ;;^UTILITY(U,$J,358.3,3090,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3090,1,4,0)
 ;;=4^354.2
 ;;^UTILITY(U,$J,358.3,3090,1,5,0)
 ;;=5^Ulnar Nerve Entrapment
 ;;^UTILITY(U,$J,358.3,3090,2)
 ;;=^268506
 ;;^UTILITY(U,$J,358.3,3091,0)
 ;;=729.1^^36^269^22
 ;;^UTILITY(U,$J,358.3,3091,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3091,1,4,0)
 ;;=4^729.1
 ;;^UTILITY(U,$J,358.3,3091,1,5,0)
 ;;=5^Fibromyalgia
 ;;^UTILITY(U,$J,358.3,3091,2)
 ;;=Fibromyalgia^80160
 ;;^UTILITY(U,$J,358.3,3092,0)
 ;;=438.20^^36^269^16
 ;;^UTILITY(U,$J,358.3,3092,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3092,1,4,0)
 ;;=4^438.20
 ;;^UTILITY(U,$J,358.3,3092,1,5,0)
 ;;=5^Cva With Hemiplegia (Late Effect)
 ;;^UTILITY(U,$J,358.3,3092,2)
 ;;=CVA w/Hemiplegia^317910
 ;;^UTILITY(U,$J,358.3,3093,0)
 ;;=438.12^^36^269^15
 ;;^UTILITY(U,$J,358.3,3093,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3093,1,4,0)
 ;;=4^438.12
 ;;^UTILITY(U,$J,358.3,3093,1,5,0)
 ;;=5^Cva With Dysphasia (Late Effect)
 ;;^UTILITY(U,$J,358.3,3093,2)
 ;;=Stroke w/Dysphasia^317908
 ;;^UTILITY(U,$J,358.3,3094,0)
 ;;=356.8^^36^269^52
 ;;^UTILITY(U,$J,358.3,3094,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3094,1,4,0)
 ;;=4^356.8
 ;;^UTILITY(U,$J,358.3,3094,1,5,0)
 ;;=5^Peripheral Neuropathy, Idiopathic
 ;;^UTILITY(U,$J,358.3,3094,2)
 ;;=Peripheral Neuropathy, Idio^268525
 ;;^UTILITY(U,$J,358.3,3095,0)
 ;;=337.20^^36^269^59
 ;;^UTILITY(U,$J,358.3,3095,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3095,1,4,0)
 ;;=4^337.20
 ;;^UTILITY(U,$J,358.3,3095,1,5,0)
 ;;=5^Reflexive Sympathetic Dystrophy
 ;;^UTILITY(U,$J,358.3,3095,2)
 ;;=Reflexive Sympathetic Dystrophy^295799
 ;;^UTILITY(U,$J,358.3,3096,0)
 ;;=294.8^^36^269^19
 ;;^UTILITY(U,$J,358.3,3096,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3096,1,4,0)
 ;;=4^294.8
 ;;^UTILITY(U,$J,358.3,3096,1,5,0)
 ;;=5^Dementia, Other
 ;;^UTILITY(U,$J,358.3,3096,2)
 ;;=^268044
 ;;^UTILITY(U,$J,358.3,3097,0)
 ;;=438.6^^36^269^13
 ;;^UTILITY(U,$J,358.3,3097,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3097,1,4,0)
 ;;=4^438.6
 ;;^UTILITY(U,$J,358.3,3097,1,5,0)
 ;;=5^Cva W/Dysesthesia (Late Effect)
 ;;^UTILITY(U,$J,358.3,3097,2)
 ;;=CVA w/Dysesthesia (late effect)^328503
 ;;^UTILITY(U,$J,358.3,3098,0)
 ;;=438.7^^36^269^14
 ;;^UTILITY(U,$J,358.3,3098,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3098,1,4,0)
 ;;=4^438.7
 ;;^UTILITY(U,$J,358.3,3098,1,5,0)
 ;;=5^Cva W/Vision Changes (Late Effect)
 ;;^UTILITY(U,$J,358.3,3098,2)
 ;;=CVA w/Vision Changes (late effect)^328504
 ;;^UTILITY(U,$J,358.3,3099,0)
 ;;=438.84^^36^269^12
 ;;^UTILITY(U,$J,358.3,3099,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3099,1,4,0)
 ;;=4^438.84
 ;;^UTILITY(U,$J,358.3,3099,1,5,0)
 ;;=5^Cva W/Ataxia (Late Effect)
 ;;^UTILITY(U,$J,358.3,3099,2)
 ;;=CVA w/Ataxia (late effect)^328507
 ;;^UTILITY(U,$J,358.3,3100,0)
 ;;=434.91^^36^269^4
 ;;^UTILITY(U,$J,358.3,3100,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3100,1,4,0)
 ;;=4^434.91
 ;;^UTILITY(U,$J,358.3,3100,1,5,0)
 ;;=5^CVA,Acute Onset
 ;;^UTILITY(U,$J,358.3,3100,2)
 ;;=^295738
 ;;^UTILITY(U,$J,358.3,3101,0)
 ;;=V12.54^^36^269^23
 ;;^UTILITY(U,$J,358.3,3101,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3101,1,4,0)
 ;;=4^V12.54
 ;;^UTILITY(U,$J,358.3,3101,1,5,0)
 ;;=5^HX Stroke w/o Residuals
 ;;^UTILITY(U,$J,358.3,3101,2)
 ;;=^335309
 ;;^UTILITY(U,$J,358.3,3102,0)
 ;;=333.94^^36^269^60
 ;;^UTILITY(U,$J,358.3,3102,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3102,1,4,0)
 ;;=4^333.94
 ;;^UTILITY(U,$J,358.3,3102,1,5,0)
 ;;=5^Restless Leg Syndrome
 ;;^UTILITY(U,$J,358.3,3102,2)
 ;;=^105368
 ;;^UTILITY(U,$J,358.3,3103,0)
 ;;=345.90^^36^269^63
 ;;^UTILITY(U,$J,358.3,3103,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3103,1,4,0)
 ;;=4^345.90
 ;;^UTILITY(U,$J,358.3,3103,1,5,0)
 ;;=5^Seizure Disorder NOS
 ;;^UTILITY(U,$J,358.3,3103,2)
 ;;=^268477
 ;;^UTILITY(U,$J,358.3,3104,0)
 ;;=339.00^^36^269^6
 ;;^UTILITY(U,$J,358.3,3104,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3104,1,4,0)
 ;;=4^339.00
 ;;^UTILITY(U,$J,358.3,3104,1,5,0)
 ;;=5^Cluster Headache, Unsp
 ;;^UTILITY(U,$J,358.3,3104,2)
 ;;=^336741
 ;;^UTILITY(U,$J,358.3,3105,0)
 ;;=339.01^^36^269^8
 ;;^UTILITY(U,$J,358.3,3105,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3105,1,4,0)
 ;;=4^339.01
 ;;^UTILITY(U,$J,358.3,3105,1,5,0)
 ;;=5^Cluster Headache,Episodic
 ;;^UTILITY(U,$J,358.3,3105,2)
 ;;=^336545
 ;;^UTILITY(U,$J,358.3,3106,0)
 ;;=339.02^^36^269^7
 ;;^UTILITY(U,$J,358.3,3106,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3106,1,4,0)
 ;;=4^339.02
 ;;^UTILITY(U,$J,358.3,3106,1,5,0)
 ;;=5^Cluster Headache,Chronic
 ;;^UTILITY(U,$J,358.3,3106,2)
 ;;=^336546
 ;;^UTILITY(U,$J,358.3,3107,0)
 ;;=339.81^^36^269^26
